LUNGevity Foundation
She has a bachelor's in molecular biology from Princeton University and a master's in cancer biology, with a specialization in patient-based research, from The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences. She also serves on the faculty of MD Anderson UTHealth Graduate School.
Dr. Byers earned her medical degree from Baylor College of Medicine. Following her internal medicine residency at Johns Hopkins School of Medicine, she returned to her home state of Texas for oncology fellowship training at MD Anderson. In 2010, Dr. Byers joined the faculty at MD Anderson. Using proteomic, gene expression, and genomic profiling assays, she has identified several promising molecular targets for treating lung cancer. These include the identification of poly ADP-ribose polymerase 1 (PARP1) and other genes involved in repairing DNA damage as novel therapeutic targets for small cell lung cancer (SCLC).
This person is not in the org chart
This person is not in any offices
LUNGevity Foundation
2 followers
LUNGevity Foundation is the nation's leading lung cancer organization focused on improving outcomes for people with lung cancer through research, policy initiatives, education, support, and engagement for patients, survivors, and caregivers. LUNGevity seeks to make an immediate impact on quality of life and survivorship for everyone touched by the disease—while promoting health equity by addressing disparities throughout the care continuum. LUNGevity works tirelessly to advance research into early detection and more effective treatments, provide information and educational tools to empower patients and their caregivers, promote impactful public policy initiatives, and amplify the patient voice through research and engagement. The organization provides an active community for patients and survivors—and those who help them live longer and better lives.